Balance Sheet Data
Heron Therapeutics, Inc. (HRTX)
$1.49
+0.08 (+5.67%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 332.37 | 390.97 | 208.49 | 157.58 | 84.85 | 302.76 | 356.69 | 420.22 | 495.06 | 583.24 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 64.65 | 39.88 | 41.85 | 35.50 | 52.05 | 62.77 | 73.96 | 87.13 | 102.65 | 120.93 |
| Account Receivables (%) | ||||||||||
| Inventories | 39.03 | 24.97 | 41.90 | 48.38 | 54.57 | 56.19 | 66.20 | 77.99 | 91.88 | 108.24 |
| Inventories (%) | ||||||||||
| Accounts Payable | 17.09 | 2.76 | 0.53 | 3.80 | 3.23 | 8.10 | 9.55 | 11.25 | 13.25 | 15.61 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -9.17 | -7.15 | -6.81 | -3.02 | -1.82 | -7.51 | -8.85 | -10.43 | -12.29 | -14.48 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.